Opana ER Maker to Stop Marketing Drug as Crush-Resistant Under NY Settlement

The maker of the long-acting painkiller Opana ER has agreed to stop marketing the drug as crush-resistant, under a settlement with New York State. The company also agreed to accurately describe the risk of addiction to the drug, Reuters reports.

Under the agreement with New York State, Endo Health Solutions and Endo Pharmaceuticals will also pay a $200,000 penalty, according to New York State Attorney General Eric T. Schneiderman. He said the company’s own studies found Opana ER could be crushed and ground. “This may have bolstered Opana ER sales, but provided a false sense of security to health care providers and their patients,” according to a statement by Schneiderman’s office.

The Attorney General also found that Endo improperly instructed its sales representatives to “diminish and distort risks associated with Opana ER, including serious dangers involving addiction,” Schneiderman’s office stated.

The Attorney General found that Endo made unsupported claims comparing Opana ER to other opioids, and failed to disclose accurate information regarding studies addressing the effects of Opana ER.

Endo, in a statement, said it was “deeply committed to patient health and safety,” and said it welcomed the attorney general’s support toward reducing opioid prescription abuse.

The company said it will create an Abuse and Diversion Detection Program that requires its sales representatives to report to the company health care providers it suspects of engaging in abuse and illegal diversion of opioids. The company pledged to cease marketing opioids to problem prescribers.

Endo will post results of clinical studies on its website; encourage health care providers to seek training on appropriate opioid prescribing practices; and give health care providers information about addiction treatment resources for their patients.

    User Picture

    Jim Moser

    March 18, 2016 at 7:47 PM

    OPANA IS THE NUMBER ONE PURCHASE CHOICE OF OPIOID ABUSERS on the dark net (the underworld of the internet) where drugs are openly purchased and shipped to your door via the USPS , FedEx, etc….

    Best high and duration of euphoria….. Demands a premium price as a result.

    It is shameful that Endo makes this product at all without science that makes it abuse proof, let alone market it as abuse deterrent when it is not that at all.

    Like most pharmaceutical companies, Endo’s primary concern is the bottom line….

Leave a Comment

Please leave a comment below to contribute to the discussion. If you have a specific question, please contact a Parent Specialist, who will provide you with one-on-one help.

Your email address will not be published. Required fields are marked *